Synapse - Works

Results (13087)

Tyrosine kinase inhibitor (TKI) switching patterns during the first 12 months in simplicity, an observational study of chronic-phase chronic myeloid leukemia (CP-CML) patients (Pts) in routine clinical practice

Meeting Abstract

Goldberg, S.; Michallet, M.; Hehlmann, R.; Zyczynski, T.; Foreman, A.; Calimlim, B.; Paquette, R.; Simonsson, B.; Gambacorti, C.; Cortes, J. E.; more...
Blood (2016)

Fulltext@MSK | Save

NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction: Results from the expansion cohort of a phase 1/2 study

Meeting Abstract

Gertz, M. A.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Walling, J.; Kinney, G. G.; Koller, M.; Schenk, D. B.; more...
Blood (2016)

Fulltext@MSK | Save

Pembrolizumab, a PD-1 inhibitor, in patients with myelodysplastic syndrome (MDS) after failure of hypomethylating agent treatment

Meeting Abstract

Garcia-Manero, G.; Tallman, M. S.; Martinelli, G.; Ribrag, V.; Yang, H.; Balakumaran, A.; Chlosta, S.; Zhang, Y.; Smith, B. D.
Blood (2016)

Fulltext@MSK | Save

Implications of concurrent ibrutinib therapy on CAR T-cell manufacturing and phenotype and on clinical outcomes following CD19-targeted CAR T-cell administration in adults with relapsed/refractory CLL

Meeting Abstract

Geyer, M. B.; Park, J. H.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T. J.; Sadelain, M. W.; Brentjens, R. J.
Blood (2016)

Fulltext@MSK | Save

Multicolor flow cytometry and multi-gene next generation sequencing are complimentary and highly predictive for relapse in acute myeloid leukemia following allogeneic hematopoietic stem cell transplant

Meeting Abstract

Getta, B. M.; Devlin, S.; Maloy, M. A.; Mohanty, A.; Arcila, M.; Tallman, M. S.; Levine, R. L.; Giralt, S. A.; Roshal, M.
Blood (2016)

Fulltext@MSK | Save

Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia (AML)

Meeting Abstract

Fathi, A. T.; Erba, H. P.; Lancet, J. E.; Stein, E. M.; Ravandi, F.; Faderl, S.; Walter, R. B.; Advani, A.; DeAngelo, D. J.; Kovacsovics, T. J.; more...
Blood (2016)

Fulltext@MSK | Save

Importance of achieving complete remission (CR) after intensive therapy for acute myeloid leukemia (AML) in older adults age >= 60 years: Analysis of risk factors for early mortality and re-induction, and impact of quality of response on overall survival (OS) in the ECOG-ACRIN E2906 randomized trial

Meeting Abstract

Foran, J. M.; Sun, Z.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D. A.; Zhang, Y.; more...
Blood (2016)

Fulltext@MSK | Save

Frequent clinical overlap of histiocytic neoplasms and WHO-classified myeloid malignancies leads to functional insights into the cell-of-origin of histiocytoses

Meeting Abstract

Durham, B. H.; Yoshimi, A.; Papo, M.; Chung, Y. R.; Ozkaya, N.; Ganzel, C.; Dogan, A.; Hyman, D. M.; Park, C. Y.; Rampal, R. K.; more...
Blood (2016)

Fulltext@MSK | Save

Cooperative gene repression by DNA methylation and LSD1-mediated enhancer inactivation in acute myeloid leukemia

Meeting Abstract

Duy, C.; Teater, M.; Garrett-Bakelman, F. E.; Lee, T. C.; Meydan, C.; Glass, J. L.; Li, M.; Mohammad, H.; Smitheman, K.; Shih, A. H.; more...
Blood (2016)

Fulltext@MSK | Save

Risk of bleeding in 9,429 patients with Philadelphia-negative myeloproliferative neoplasms: A population-based study from Sweden

Meeting Abstract

Creignou, M.; Bower, H.; Andersson, T. M. L.; Landtblom, A. R.; Dickman, P. W.; Björkholm, M.; Kristinsson, S. Y.; Hultcrantz, M.
Blood (2016)

Fulltext@MSK | Save